Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Argenx’ FcRn inhibitor efgartigimod is a multi-blockbuster in the making. However, macro headwinds for the biotech sector and a relatively slow 2021 provide for an interesting long-term entry point. We raise our price target to € 300/share and rating to Buy. Our View: Today we publish our company note on Argenx: a decade-long opportunity in autoimmunity. A head-to-head comparison of 5 FcRn assets in development shows that with efgartigimod, Argenx owns a first-in-class and potentially best-in-c...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.